Cannara Biotech, Inc. · TSX:LOVE
Cannara Biotech — Investor Presentation (May 2025)
20 slides from Cannara Biotech's investor presentation, May 2025
Slide 1: Premium-Grade Cannabis at Scale
TSXV: LOVE | OTCQB: LOVFF | FRA: 8CB0 PREMIUM-GRADE CANNABIS AT SCALE INVESTOR DECK Q2 FISCAL 2025 (AS OF FEBRUARY 28, 2025)
Slide 2: Disclaimer
General Disclaimer This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the information contained in the Company’s most recent Annual Information Form, as well as in the Company’s most recent consolidated financial statements, together with the notes
Slide 3: Forward-Looking Statements
General Forward-Looking Statements This presentation may contain “forward-looking information” within the meaning of Canadian securities legislation (“forward-looking statements”). These forward-looking statements are made as of the date of this presentation and the Company does not intend, and does
Slide 4: An Emerging Leader In Canada
An Emerging Leader In Canada Vertically-integrated Licensed Producer of premium-grade cannabis products Canada’s 7th Top LP by sales1 Q2 2025 Financials2 • Net Revenue: $26.6 M • Gross Profit: $10.8M Overview 4th largest producer based • Adjusted EBITDA2: $7.1M on facilities square footage Strategy
Slide 5: Canadian Recreational Cannabis Market
Canadian Recreational Cannabis Market 2ND Largest Cannabis Market in the world Legal Cannabis Market expected to Monthly Retail Sales of Legal reach Cannabis Stores in Canada from ~$9.81 billion CDN (US$6.58 B) by 20291 October 2018 to March 2025 2 7 Retail sales in million CDN dollars Overview 500
Slide 6: Two Quebec Based Mega Facilities
Two Quebec Based Mega Facilities Completely automated equipped with cutting edge technologies Overview Strategy Financials Leadership Summary Each activated zone has been designed to replicate indoor growing conditions eliminating variability and maximizing quality. Farnham Facility Valleyfield Faci
Slide 7: Why Quebec
Why Quebec Average Electricity Rates By Province In Cents Per Kw Hour Quebec has the lowest electricity rates in Canada QC MB BC ON SK NS AB 5.3¢/kWh 5.4¢/kWh 7.4¢/kWh 10.3¢/kWh 11.1¢/kWh 11.6¢/kWh 14.1¢/kWh Overview Strategy Financials Quebec has the highest barriers Leadership 784 503 112 174 Summ
Slide 8: Scaling Production Assets
Scaling Production Assets Cannara’s Estimated Annual Production Capacity in kg 80,000 75,000 70,000 Overview 62,500 Annualized Production (kg) Strategy 60,000 Financials 50,000 Leadership 50,000 Summary 39,500 40,000 33,500 30,500 30,000 Total owned potential production 22,000 capacity of up to 100,
Slide 9: Competitive Advantage
Competitive Advantage Scalable Quality Innovation in Products & Genetics • Deliver true to craft like procedures including hang drying and • Diverse portfolio of products: dried flower, pre-rolls, hand trimming cannabis to ensure quality. infused pre-rolls, milled flower, vapes, edibles, hash and ot
Slide 10: Delivering Premium Quality Cannabis
Delivering Premium Quality Cannabis Focusing on high cannabinoid content and rich flavourful cannabis Our cannabis is grown using Rare genetics Hang dried & slow cured methods inspired by the most sophisticated markets in the Overview world: Strategy Financials Leadership Summary Quality Accessibili
Slide 11: Portfolio of Brands
Portfolio of Brands - Overview Strategy Financials Leadership Summary Q2 FY2025 11
Slide 12: Cannara Strategy
Cannara Strategy Delivering a premium-quality product at scale and at lower prices for consumers is at the heart of our strategy Purposeful growth by focusing on the Canadian legal market that is expected to reach ~$9.81 billion CDN (US$6.58 B) by 20291 Overview Respond to market demand by increasin
Slide 13: Scaling Sales
Scaling Sales Cannabis Revenue Growth Trajectory as Valleyfield Production Scales Up $26.6 $24.0 Overview $22.1 Strategy Financials $18.8 $18.5 $18.3 Leadership $17.2 Summary $14.9 $12.0 $11.1 $9.2 $9.4 Q2 FY2025 13
Slide 14: Scaling Sales
Scaling Sales Cannabis Revenue Growth Trajectory as Valleyfield Production Scales Up $26.6 $24.0 Overview $22.1 Strategy Financials $18.8 $18.5 $18.3 Leadership $17.2 Summary $14.9 $12.0 $11.1 $9.2 $9.4 Q2 FY2025 14
Slide 15: Increasing Our Market Share
Increasing Our Market Share Q2 2025 – Highest National Market Share to-date at 3.9% # Top-performing Products Quebec’s #1 Infused pre-roll Overview Retail Market Share Province March 2025 Q2 2025 Q1 2025 1 # Canada’s #1 Premium Live Resin Vape 1 Strategy # QC 13.4% 12.8% 12.5% Financials Leadership
Slide 16: Q2 2025 Selected Financial Information
Q2 2025 Selected Financial Information Three and six-month periods ended Current Capitalization Table February 28, 2025 YTD Q2 91,433,135 625,000 $51.7M $26.6M $20.6M $10.8M Overview 5,095,060 3,166,667 Strategy Financials 40% 41% Leadership $13.1M $7.1M Summary 202,500 $5.6M $3.3M $3.3M ($2.6M) $0.
Slide 17: Executive Leadership Team
Executive Leadership Team Zohar is an entrepreneur who has Nicholas Sosiak, CPA, is the Avi has been in the information launched several successful businesses. dynamic and hands-on CFO technology industry for over 20 He has founded, advised and invested of Cannara Biotech, years. He specializes in i
Slide 18: Executive Leadership Team
Executive Leadership Team ZOHAR KRIVOROT MARY DUROCHER JUSTIN COHEN CHAIRMAN & CEO DIRECTOR DIRECTOR Zohar is a seasoned entrepreneur who Mary has been involved in the Justin Cohen is a seasoned executive has built and grown multiple successful cannabis industry since the specializing in scaling bus
Slide 19: In Summary Positioned for National Success
In Summary Well capitalized, fast-growing business Operating with strong margins and with an established history of execution with a focus on positive EBITDA, cash flow and profitability Offering customers the highest value Overview products at disruptive low prices Strategy State of the art Quebec
Slide 20: Thank You
TSXV: LOVE | OTCQB: LOVFF | FRA: 8CB0 THANK YOU Overview Strategy www.cannara.ca Financials Leadership Summary investors.cannara.ca www.instagram.com/cannarabiotech www.facebook.com/cannarabiotech CANNARA HEADQUARTERS FARNHAM FACILITY VALLEYFIELD FACILITY 333 Decarie Blvd., Suite 200 1144 Boulevard